OE-136 Prognostic Value of Combination of Adrenomedullin and Brain Natriuretic Peptide in Patients with Stable Cardiovasculer Disease(OE23,Heart Failure (Pathophysiology) (M),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
Kimihiko Ishimura(Dokkyo University), Hiroaki Matsuoka(Social Welfare Department), Fumiki Yoshihara(National Cerebral and Cardiovascular Center), Yuhei Kawano(Fukuoka Institute of Technology), Toshio Nishikimi(Kyoto University), Kenji Kangawa(National Cerebral and Cardiovascular Center), Takeshi Horio, Kazuyoshi Tadokoro(Dokkyo Medical University), Tikako Iemura
Japanese Circulation Journal-english Edition
March 1, 2009
Cited by 8
Related Papers
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)—Chapter 2
|Hypertension Research|2009|485
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
|Journal of Clinical Investigation|1994|478